A Short Scale Trial to Study and Evaluate the Safety and Efficacy of a Herbal Composition; Verona Anti-BPH Capsule to Treat Benign Prostatic Hyperplasia in Men Older than 40 Years of Age
Abstract
Benign Prostatic Hyperplasia (BPH) is a condition that causes
the proliferation of the cells of the prostate causing urine retention, renal insufficiency, bladder
calculi, recurrent Lower Urinary Tract Infections (LUTS) and in complicated cases, hematuria
with unbearable pain. The trial was conducted to study the safety and efficacy of novel herbal
product Verona anti- BPH capsules at a local clinic of Sharafi Goth, Karachi Pakistan.
Benign Prostatic Hyperplasia (BPH) is one major condition. The prevalence of
the disease increases to around 8-60% in men at the age of 40 years which is caused mainly by
hormonal change, lifestyle changes or diet. The disease is mainly defined as increased cellular
proliferation of the prostate glands or an enlarged prostate. 50% men of age 65 years and
above of the total population of Pakistan are at risk of having Benign Prostatic Hyperplasia
(BPH).
This was a single blind, placebo control phase I clinical trial. A total of 35 patients
were enrolled in the study, out of which 2 patients got dropped out. 23 patients received Verona
anti-BPH capsules and 10 patients received placebo. The sample paired t-test was applied
to evaluate the significant level.
Verona Anti-BPH capsules were found safe and effective in the treatment of Benign
Prostatic Hyperplasia (anti-BPH).
Verona anti-BPH capsules were known to be effective with no harmful side effects.
Read the paper
Related studies
- Treatment of non-metastatic castration-resistant prostate cancer: facing age-related comorbidities and drug–drug interactions
- The Efficacy of Flogofilm® in the Treatment of Chronic Bacterial Prostatitis as an Adjuvant to Antibiotic Therapy: A Randomized Prospective Trial
- Inhibition of growth and contraction in human prostate stromal cells by silencing of NUAK1 and -2, and by the presumed NUAK inhibitors HTH01-015 and WZ4003
- Effectiveness and Safety of a New Nutrient Fixed Combination Containing Pollen Extract Plus Teupolioside, in the Management of LUTS in Patients with Benign Prostatic Hypertrophy: A Pilot Study
- Extract from Cucurbita pepo improves BPH symptoms without affecting sexual function: a 24-month noninterventional study
- Aquablation vs. holmium laser enucleation of the prostate for benign prostatic hyperplasia: a 150-patients prospective comparative multicenter study
Go deeper in Evidence Hub
Evidence Hub adds a study data sheet (design, sample size, evidence level, key numbers), an AI summary and a chat grounded in the paper's text.